Nintedanib+Letrozole in Postmenopausal Women With Breast Cancer: Clinical Trial Safety and Pharmacodynamics

NCT02619162 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Nintedanib
DRUG: Letrozole

Sponsor

Centro Nacional de Investigaciones Oncologicas CARLOS III

Collaborators

[object Object]
[object Object]
[object Object]